|
|
|
|
|
| First Name: | Martijn | | Last Name: | Gebbink | | Title: | dr | | Affiliation: | Crossbeta Biosciences | | Street Address 1: | Padualaan 8 | | City: | Utrecht | | Zip/Postal Code: | 3584 CH | Country/Territory: | Netherlands | | Phone: | +31302538823 | | Email Address: |  |
Disclosure:
(view policy)
|
Member reports the following financial or other potential conflicts of interest: [Last Modified: 13 October 2011]
shareholder & employee of Crossbeta Biosciences
|
|
|
View all comments by Martijn Gebbink
|
Alzheimer Disease, Parkinson Disease, Polyglutamine Disorders (Huntington's, etc.), Tauopathies
|
Animal Models, Neurobiology, Neuropathology, Diagnosis, Drug screening, Tau/Cytoskeleton, A-beta PP/A-beta, Apoptosis/Cell cycle, Neuroimmunology, Oxidative Stress, Protein structure/chemistry, Signal transduction
|
http://linkinghub.elsevier.com/retrieve/pii/S0014-5793(09)00459-1
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518075/?tool=pubmed
http://www.ncbi.nlm.nih.gov/pubmed/18303094
|
surrogate endopoints in clinical studies (biomarkers) |
combination of therapy in clinical setting |
amyloid-beta toxicity and receptors for amyloid |
|
|
|
|
|
|
Home
